The first-ever oral therapy to treat relapsing-remitting multiple sclerosis has been approved by the FDA. University of Washington neurologist and MS specialist, Dr. Sylvia Lucas, explains what it means and gives guidance for patients.
Sylvia Lucas, M.D., Ph.D.
Clinical Professor of Neurology and Rehabilitation Medicine, UW MedicineDr. Sylvia Lucas is Medical Director of the Headache Center at the University of Washington Medical Center and Clinical Professor of Neurology at the University of Washington School of Medicine. She has extensive experience in lectures, research and has authored many pieces on various neurological topics. Dr. Lucas is board certified in neurology. more >